SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001746473-24-000123
Filing Date
2024-07-12
Accepted
2024-07-12 18:22:25
Documents
1
Period of Report
2024-07-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1720822935.html 4  
1 FORM 4 wk-form4_1720822935.xml 4 5314
  Complete submission text file 0001746473-24-000123.txt   6795
Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PLIANT THERAPEUTICS, INC. 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Coulie Bernard (Reporting) CIK: 0001808895 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39303 | Film No.: 241115426